Citi, Jefferies raise TP on Australia's Ansell over better performance and outlook
BUZZ-Citi, Jefferies raise TP on Australia's Ansell over better performance and outlook ** Analysts at Jefferies raise price target for Ansell ANN.AX, citing successful program and integration delivery while progressively implementing price increases
** Brokerage raises PT to A$44.50/shr from A$38.20/shr, retains "buy" rating for stock
** The medical glove maker on Monday said it expects FY27 adj EPS of 158 cents to 170 cents, higher than 148.6 cents in FY26
** We expect ongoing prioritisation of top 5 brands and the newest products will support sales at this time of heightened price negotiation - Jefferies
** Analysts at Citi also raise target price for stock to A$39.50/shr from A$33.50/shr, retain "neutral" rating
** We suspect ANN may not be "done" yet because new strategic priorities suggest a period of optimizing focus for higher-margin customers and more profitable brands - Citi
** ANN stock up 9.2% YTD, as of last close
(Reporting by Shivangi Lahiri in Bengaluru)
Recent news on Ansell
See all newsAustralia's Ansell rises to record high, Citi keeps 'neutral' rating
Citi remains neutral on Australia's Ansell; says competition reports steady demand
Citi, Jefferies raise TP on Australia's Ansell over better performance and outlook
Australia's Ansell logs best day in six-years after profit doubles, upbeat FY27 forecast
Brief: Ansell Posts FY Sales Of $2,140.2 Million